NEKTAR THERAPEUTICS — Director's Dealing 2016

Jun 3, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2016-06-01

Reporting Person: Nicholson John (SVP & Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-01	Stock Option	$15.53	A	100000	Acquired	2024-05-31	Common Stock (100000)	Direct

Footnotes

F1: This stock option vests in equal monthly installments over the 4-year period following the grant date.